• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Minerva Neurosciences, Inc - Common Stock (NQ:NERV)

4.450 -0.250 (-5.32%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 52,296
Open 4.750
Bid (Size) 4.460 (500)
Ask (Size) 4.750 (24,200)
Prev. Close 4.700
Today's Range 4.380 - 4.750
52wk Range 1.150 - 12.46
Shares Outstanding 6,993,406
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
November 19, 2025
From Minerva Neurosciences, Inc
Via GlobeNewswire
News headline image
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
November 05, 2025
From Minerva Neurosciences, Inc
Via GlobeNewswire

Performance

YTD
+13.5%
+13.5%
1 Month
+13.8%
+13.8%
3 Month
+89.4%
+89.4%
6 Month
+164.9%
+164.9%
1 Year
+104.6%
+104.6%

More News

Read More
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
October 28, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
October 22, 2025
Via Benzinga
News headline image
Top movers in Wednesday's session ↗
October 22, 2025
Via Chartmill
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
October 22, 2025
Via Chartmill
News headline image
Minerva Neurosciences Stock Hits Near 2-Year High On FDA Pathway, $200M Boost — Retail Sees FDA Catalyst ↗
October 22, 2025
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
October 21, 2025
Via Benzinga
News headline image
Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial ↗
October 21, 2025
Via Benzinga
News headline image
These stocks are the most active in today's session ↗
October 21, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
October 21, 2025
Via Benzinga
News headline image
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings ↗
October 21, 2025
Via Benzinga
News headline image
These stocks that are showing activity before the opening bell on Tuesday. ↗
October 21, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
October 21, 2025
Via Benzinga
News headline image
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation
October 21, 2025
From Minerva Neurosciences, Inc
Via GlobeNewswire
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
October 08, 2025
Via Chartmill
News headline image
Top movers in Wednesday's session ↗
October 08, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
August 14, 2025
Via Benzinga
News headline image
Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results
August 14, 2025
From Minerva Neurosciences, Inc
Via GlobeNewswire
News headline image
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
May 13, 2025
From Minerva Neurosciences, Inc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
April 14, 2025
Via Benzinga
News headline image
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
February 25, 2025
From Minerva Neurosciences, Inc
Via GlobeNewswire
News headline image
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
November 05, 2024
From Minerva Neurosciences, Inc
Via GlobeNewswire
News headline image
NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024 ↗
August 06, 2024
Via InvestorPlace
News headline image
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
August 06, 2024
From Minerva Neurosciences, Inc
Via GlobeNewswire

Frequently Asked Questions

Is Minerva Neurosciences, Inc - Common Stock publicly traded?
Yes, Minerva Neurosciences, Inc - Common Stock is publicly traded.
What exchange does Minerva Neurosciences, Inc - Common Stock trade on?
Minerva Neurosciences, Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Minerva Neurosciences, Inc - Common Stock?
The ticker symbol for Minerva Neurosciences, Inc - Common Stock is NERV on the Nasdaq Stock Market
What is the current price of Minerva Neurosciences, Inc - Common Stock?
The current price of Minerva Neurosciences, Inc - Common Stock is 4.450
When was Minerva Neurosciences, Inc - Common Stock last traded?
The last trade of Minerva Neurosciences, Inc - Common Stock was at 01/09/26 04:00 PM ET
What is the market capitalization of Minerva Neurosciences, Inc - Common Stock?
The market capitalization of Minerva Neurosciences, Inc - Common Stock is 31.12M
How many shares of Minerva Neurosciences, Inc - Common Stock are outstanding?
Minerva Neurosciences, Inc - Common Stock has 31M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap